Toujeo (Long-acting Recombinant Human Insulin Analogue) / Sanofi  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Toujeo (Long-acting Recombinant Human Insulin Analogue) / Sanofi
NCT05155917: Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care

Recruiting
2
70
RoW
Insulin Glargine 300 UNT/ML [Toujeo]
Changhua Christian Hospital
Hyperglycaemic Crisis in Diabetes Mellitus, Diabetic Ketoacidosis, Hyperglycaemic Hyperosmolar Nonketotic Syndrome
01/24
01/24

Download Options